speb/financial-data huggingface dataset:
GENESYS.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 3368881000.00
GENESYS.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
GENESYS.NS balance_sheet (quarterly, 2025-09-30) — Payables: 415311000.00
GENESYS.NS balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 24830000.00
GENESYS.NS income_statement (quarterly, 2025-09-30) — Pretax Income: 151125000.00
GENESYS.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 384543000.00
GENESYS.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 156203000.00
GENESYS.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 41718912.00
GENESYS.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 6833500000.00
GENESYS.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 4734178000.00
GENESYS.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
GENESYS.NS income_statement (quarterly, 2025-09-30) — Tax Provision: 30608000.00
GENESYS.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.20
GENESYS.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 9202423000.00
GENESYS.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 6925319000.00
GENESYS.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 1466869000.00
GENESYS.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 6848545000.00
GENESYS.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 625720000.00
GENESYS.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 2353878000.00
GENESYS.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 3185994000.00
GENESYS.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 246684000.00
GENESYS.NS balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 75892000.00
GENESYS.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 3909235000.00
GENESYS.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 280539000.00
GENESYS.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 757771000.00
GENESYS.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 43724000.00
GENESYS.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 0.25
GENESYS.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 487868000.00
GENESYS.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 168101000.00
GENESYS.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 168101000.00
GENESYS.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 43724000.00
GENESYS.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.25
GENESYS.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 10931000.00
GENESYS.NS income_statement (quarterly, 2025-12-31) — EBIT: 49668000.00
GENESYS.NS income_statement (quarterly, 2025-12-31) — EBITDA: 217769000.00
GENESYS.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 269903000.00
GENESYS.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 28378000.00
GENESYS.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 28378000.00
GENESYS.NS income_statement (quarterly, 2025-12-31) — Minority Interests: 430000.00
GENESYS.NS income_statement (quarterly, 2025-12-31) — Net Income: 10931000.00
GENESYS.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 10931000.00
GENESYS.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 10501000.00
GENESYS.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 10931000.00
GENESYS.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 10931000.00
GENESYS.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 10501000.00
GENESYS.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -28378000.00
GENESYS.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -28378000.00
GENESYS.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 268731000.00
GENESYS.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 46604400.00
GENESYS.NS income_statement (quarterly, 2025-12-31) — Operating Income: -10636000.00
GENESYS.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 757771000.00
GENESYS.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 111266000.00
GENESYS.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 112438000.00
GENESYS.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
GENESYS.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 21290000.00
GENESYS.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 487868000.00
GENESYS.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 168101000.00
GENESYS.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: -50962000.00
GENESYS.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -15288600.00
GENESYS.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 10789000.00
GENESYS.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.30
GENESYS.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 768407000.00
GENESYS.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: -50962000.00
GENESYS.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -50962000.00
GENESYS.NS income_statement (annual, 2026-03-31) — +Operating Expense: 1068471000.00
GENESYS.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 325812000.00
GENESYS.NS income_statement (annual, 2026-03-31) — +Total Revenue: 3278089000.00
GENESYS.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 1042178000.00
GENESYS.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 407363000.00
GENESYS.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 407363000.00
GENESYS.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 2032449000.00
GENESYS.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 2032449000.00
GENESYS.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 358621000.00
GENESYS.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 358621000.00
GENESYS.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 40666776.00
GENESYS.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 3.04
GENESYS.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 33438000.00
GENESYS.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -597565000.00
GENESYS.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 127643000.00
GENESYS.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 127643000.00
GENESYS.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 208952000.00
GENESYS.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 208952000.00
GENESYS.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 91968000.00
GENESYS.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 91968000.00
GENESYS.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 4175266000.00
GENESYS.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 4175266000.00
GENESYS.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: -1020334000.00
GENESYS.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: 16077000.00
GENESYS.NS cash_flow (annual, 2026-03-31) — Change In Payable: 1402000.00
GENESYS.NS cash_flow (annual, 2026-03-31) — Change In Receivables: 102336000.00
GENESYS.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -900519000.00
GENESYS.NS cash_flow (annual, 2026-03-31) — Changes In Cash: 45402000.00
GENESYS.NS balance_sheet (annual, 2026-03-31) — Common Stock: 208952000.00
GENESYS.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 208952000.00
GENESYS.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 7035223000.00
GENESYS.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 7035223000.00
GENESYS.NS cash_flow (annual, 2026-03-31) — Common Stock Issuance: 1054257000.00
GENESYS.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 12332000.00
GENESYS.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 12332000.00
GENESYS.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 1765863000.00
GENESYS.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 546409000.00
GENESYS.NS balance_sheet (annual, 2026-03-31) — Current Assets: 6307483000.00
GENESYS.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 6307483000.00
GENESYS.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 56589000.00
GENESYS.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 56589000.00
GENESYS.NS balance_sheet (annual, 2026-03-31) — Current Debt: 1554477000.00
GENESYS.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 1554477000.00
GENESYS.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 1611066000.00
GENESYS.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 1611066000.00
GENESYS.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 2420669000.00
GENESYS.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 2420669000.00
GENESYS.NS cash_flow (annual, 2026-03-31) — Depreciation: 649703000.00
GENESYS.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 649703000.00
GENESYS.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 649703000.00
GENESYS.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 171100000.00
GENESYS.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 649703000.00
GENESYS.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 171100000.00
GENESYS.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 40666776.00
GENESYS.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 3.04
GENESYS.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 325761000.00
GENESYS.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 123627000.00
GENESYS.NS income_statement (annual, 2026-03-31) — EBIT: 589700000.00
GENESYS.NS income_statement (quarterly, 2026-03-31) — EBIT: 204441000.00
GENESYS.NS income_statement (annual, 2026-03-31) — EBITDA: 1239403000.00
GENESYS.NS income_statement (quarterly, 2026-03-31) — EBITDA: 375541000.00
GENESYS.NS cash_flow (annual, 2026-03-31) — Effect Of Exchange Rate Changes: 13128000.00
GENESYS.NS cash_flow (annual, 2026-03-31) — End Cash Position: 91968000.00
GENESYS.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: 1387632000.00
GENESYS.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: -439470000.00
GENESYS.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: -2995000.00
GENESYS.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 2330961000.00
GENESYS.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 2330961000.00
GENESYS.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 550324000.00
GENESYS.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 550324000.00
GENESYS.NS income_statement (annual, 2026-03-31) — Gross Profit: 1512226000.00
GENESYS.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 495769000.00
GENESYS.NS income_statement (annual, 2026-03-31) — Interest Expense: 124753000.00
GENESYS.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 33509000.00
GENESYS.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 124753000.00
GENESYS.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 33509000.00
GENESYS.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -124754000.00
GENESYS.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 56616000.00
GENESYS.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 8636964000.00
GENESYS.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 8636964000.00
GENESYS.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -1500325000.00
GENESYS.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 358621000.00
GENESYS.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 358621000.00
GENESYS.NS cash_flow (annual, 2026-03-31) — Issuance Of Capital Stock: 1054257000.00
GENESYS.NS cash_flow (annual, 2026-03-31) — Issuance Of Debt: 598250000.00
GENESYS.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 71054000.00
GENESYS.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 71054000.00
GENESYS.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 47264000.00
GENESYS.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 47264000.00
GENESYS.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 118318000.00
GENESYS.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 118318000.00
GENESYS.NS cash_flow (annual, 2026-03-31) — Long Term Debt Issuance: 0.00
GENESYS.NS cash_flow (annual, 2026-03-31) — Long Term Debt Payments: -95818000.00
GENESYS.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 130779000.00
GENESYS.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 130779000.00
GENESYS.NS balance_sheet (annual, 2026-03-31) — Minority Interest: 19293000.00
GENESYS.NS balance_sheet (quarterly, 2026-03-31) — Minority Interest: 19293000.00
GENESYS.NS income_statement (annual, 2026-03-31) — Minority Interests: -2250000.00
GENESYS.NS income_statement (quarterly, 2026-03-31) — Minority Interests: -3606000.00
GENESYS.NS cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: 1054257000.00
GENESYS.NS balance_sheet (annual, 2026-03-31) — Net Debt: 1509773000.00
GENESYS.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 1509773000.00
GENESYS.NS cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: -2430000.00
GENESYS.NS income_statement (annual, 2026-03-31) — Net Income: 325761000.00
GENESYS.NS income_statement (quarterly, 2026-03-31) — Net Income: 123627000.00
GENESYS.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 325761000.00
GENESYS.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 123627000.00
GENESYS.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 328011000.00
GENESYS.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 127233000.00
GENESYS.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 325761000.00
GENESYS.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 123627000.00
GENESYS.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 325761000.00
GENESYS.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 123627000.00
GENESYS.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 464947000.00
GENESYS.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 328011000.00
GENESYS.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 127233000.00
GENESYS.NS cash_flow (annual, 2026-03-31) — Net Intangibles Purchase And Sale: -223083000.00
GENESYS.NS income_statement (annual, 2026-03-31) — Net Interest Income: -124753000.00
GENESYS.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -33509000.00
GENESYS.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: -969375000.00
GENESYS.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 502432000.00
GENESYS.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: -95818000.00
GENESYS.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -124753000.00
GENESYS.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -33509000.00
GENESYS.NS balance_sheet (annual, 2026-03-31) — Net PPE: 550324000.00
GENESYS.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 550324000.00
GENESYS.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -364843000.00
GENESYS.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: 598250000.00
GENESYS.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 4704262000.00
GENESYS.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 4704262000.00
GENESYS.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 97283000.00
GENESYS.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 97283000.00
GENESYS.NS balance_sheet (annual, 2026-03-31) — Non Current Prepaid Assets: 25367000.00
GENESYS.NS balance_sheet (quarterly, 2026-03-31) — Non Current Prepaid Assets: 25367000.00
GENESYS.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 1290365000.00
GENESYS.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 375541000.00
GENESYS.NS income_statement (annual, 2026-03-31) — Normalized Income: 361713692.63
GENESYS.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 123627000.00
GENESYS.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 158095000.00
GENESYS.NS income_statement (annual, 2026-03-31) — Operating Income: 443755000.00
GENESYS.NS income_statement (quarterly, 2026-03-31) — Operating Income: 169957000.00
GENESYS.NS income_statement (annual, 2026-03-31) — Operating Revenue: 3278089000.00
GENESYS.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 1042178000.00
GENESYS.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 41790377.00
GENESYS.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 41790377.00
GENESYS.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 99408000.00
GENESYS.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 99408000.00
GENESYS.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 34125000.00
GENESYS.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 34125000.00
GENESYS.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 6826271000.00
GENESYS.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 6826271000.00
GENESYS.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 2330961000.00
GENESYS.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 2330961000.00
GENESYS.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: -24380000.00
GENESYS.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 51943000.00
GENESYS.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 51943000.00
GENESYS.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 196907000.00
GENESYS.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 34484000.00
GENESYS.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 418768000.00
GENESYS.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 154712000.00
GENESYS.NS balance_sheet (annual, 2026-03-31) — Other Properties: 537992000.00
GENESYS.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 537992000.00
GENESYS.NS balance_sheet (annual, 2026-03-31) — Other Receivables: 360000.00
GENESYS.NS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 360000.00
GENESYS.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 4083298000.00
GENESYS.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 4083298000.00
GENESYS.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
GENESYS.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
GENESYS.NS balance_sheet (annual, 2026-03-31) — Payables: 488936000.00
GENESYS.NS balance_sheet (quarterly, 2026-03-31) — Payables: 488936000.00
GENESYS.NS balance_sheet (annual, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 38369000.00
GENESYS.NS balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 38369000.00
GENESYS.NS income_statement (annual, 2026-03-31) — Pretax Income: 464947000.00
GENESYS.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 170932000.00
GENESYS.NS cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: 103424000.00
GENESYS.NS cash_flow (annual, 2026-03-31) — Purchase Of Intangibles: -223083000.00
GENESYS.NS cash_flow (annual, 2026-03-31) — Purchase Of Investment: -969375000.00
GENESYS.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -374482000.00
GENESYS.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 1765863000.00
GENESYS.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 546409000.00
GENESYS.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 649703000.00
GENESYS.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 171100000.00
GENESYS.NS cash_flow (annual, 2026-03-31) — Repayment Of Debt: -95818000.00
GENESYS.NS cash_flow (annual, 2026-03-31) — Sale Of Investment: 0.00
GENESYS.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 9639000.00
GENESYS.NS balance_sheet (annual, 2026-03-31) — Share Issued: 41790377.00
GENESYS.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 41790377.00
GENESYS.NS cash_flow (annual, 2026-03-31) — Short Term Debt Issuance: 598250000.00
GENESYS.NS income_statement (annual, 2026-03-31) — Special Income Charges: -50962000.00
GENESYS.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
GENESYS.NS cash_flow (annual, 2026-03-31) — Stock Based Compensation: 17496000.00
GENESYS.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 7035223000.00
GENESYS.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 7035223000.00
GENESYS.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 4704262000.00
GENESYS.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 4704262000.00
GENESYS.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: -15009307.37
GENESYS.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
GENESYS.NS income_statement (annual, 2026-03-31) — Tax Provision: 136936000.00
GENESYS.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 43699000.00
GENESYS.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.29
GENESYS.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.26
GENESYS.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -192007000.00
GENESYS.NS balance_sheet (annual, 2026-03-31) — Total Assets: 9724282000.00
GENESYS.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 9724282000.00
GENESYS.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 7082487000.00
GENESYS.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 7082487000.00
GENESYS.NS balance_sheet (annual, 2026-03-31) — Total Debt: 1729384000.00
GENESYS.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 1729384000.00
GENESYS.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 7054516000.00
GENESYS.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 7054516000.00
GENESYS.NS income_statement (annual, 2026-03-31) — Total Expenses: 2834334000.00
GENESYS.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 872221000.00
GENESYS.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 2669766000.00
GENESYS.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 2669766000.00
GENESYS.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 3416799000.00
GENESYS.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 3416799000.00
GENESYS.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 249097000.00
GENESYS.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 249097000.00
GENESYS.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 81573000.00
GENESYS.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 81573000.00
GENESYS.NS income_statement (annual, 2026-03-31) — Total Unusual Items: -50962000.00
GENESYS.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: 0.00
GENESYS.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: -50962000.00
GENESYS.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
GENESYS.NS balance_sheet (annual, 2026-03-31) — Working Capital: 3886814000.00
GENESYS.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 3886814000.00
GENF.L cash_flow (annual, 2021-12-31) — Issuance Of Debt: 0.00
GENF.L cash_flow (annual, 2021-12-31) — Long Term Debt Issuance: 0.00
GENF.L cash_flow (annual, 2021-12-31) — Net Business Purchase And Sale: 198502.00
GENF.L cash_flow (annual, 2021-12-31) — Net Foreign Currency Exchange Gain Loss: 0.00
GENF.L cash_flow (annual, 2021-12-31) — Net Issuance Payments Of Debt: 0.00
GENF.L cash_flow (annual, 2021-12-31) — Net Long Term Debt Issuance: 0.00
GENF.L cash_flow (annual, 2021-12-31) — Net PPE Purchase And Sale: 0.00
GENF.L cash_flow (annual, 2021-12-31) — Net Short Term Debt Issuance: 0.00
GENF.L cash_flow (annual, 2021-12-31) — Other Cash Adjustment Outside Changein Cash: -10832.00
GENF.L cash_flow (annual, 2021-12-31) — Other Non Cash Items: 99.00
GENF.L income_statement (annual, 2021-12-31) — Other Non Operating Income Expenses: -50000.00
GENF.L cash_flow (annual, 2021-12-31) — Purchase Of PPE: 0.00
GENF.L cash_flow (annual, 2021-12-31) — Sale Of Business: 198502.00
GENF.L cash_flow (annual, 2021-12-31) — Short Term Debt Issuance: 0.00
GENF.L income_statement (annual, 2022-12-31) — +Operating Expense: 1334943.00
GENF.L income_statement (annual, 2022-12-31) — +Total Revenue: 0.00
GENF.L balance_sheet (annual, 2022-12-31) — Accounts Payable: 83590.00
GENF.L balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 4190900.00
GENF.L income_statement (annual, 2022-12-31) — Basic Average Shares: 292506618.00
GENF.L income_statement (annual, 2022-12-31) — Basic EPS: 0.00
GENF.L cash_flow (annual, 2022-12-31) — Beginning Cash Position: 224004.00
GENF.L cash_flow (annual, 2022-12-31) — Capital Expenditure: -2480.00
GENF.L balance_sheet (annual, 2022-12-31) — Capital Stock: 87752.00
GENF.L balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 2356225.00
GENF.L balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 2356225.00
GENF.L balance_sheet (annual, 2022-12-31) — Cash Financial: 2356225.00
GENF.L cash_flow (annual, 2022-12-31) — Change In Payable: 29561.00
GENF.L cash_flow (annual, 2022-12-31) — Change In Receivables: -206339.00
GENF.L cash_flow (annual, 2022-12-31) — Change In Working Capital: -176778.00
GENF.L cash_flow (annual, 2022-12-31) — Changes In Cash: 2128712.00
GENF.L balance_sheet (annual, 2022-12-31) — Common Stock: 87752.00
GENF.L balance_sheet (annual, 2022-12-31) — Common Stock Equity: 2366473.00
GENF.L cash_flow (annual, 2022-12-31) — Common Stock Issuance: 3762920.00
GENF.L balance_sheet (annual, 2022-12-31) — Current Assets: 2615110.00
GENF.L balance_sheet (annual, 2022-12-31) — Current Liabilities: 250988.00
GENF.L cash_flow (annual, 2022-12-31) — Depreciation: 129.00
GENF.L cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 129.00
GENF.L income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 130.00
GENF.L income_statement (annual, 2022-12-31) — Depreciation Income Statement: 130.00
GENF.L income_statement (annual, 2022-12-31) — Diluted Average Shares: 292506618.00
GENF.L income_statement (annual, 2022-12-31) — Diluted EPS: 0.00
GENF.L income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -1335325.00
GENF.L income_statement (annual, 2022-12-31) — EBIT: -1334943.00
GENF.L income_statement (annual, 2022-12-31) — EBITDA: -1334813.00
GENF.L cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 4038.00
GENF.L cash_flow (annual, 2022-12-31) — End Cash Position: 2356225.00
GENF.L cash_flow (annual, 2022-12-31) — Financing Cash Flow: 3499516.00
GENF.L cash_flow (annual, 2022-12-31) — Free Cash Flow: -1370804.00
GENF.L income_statement (annual, 2022-12-31) — General And Administrative Expense: 499257.00
GENF.L income_statement (annual, 2022-12-31) — Interest Expense: 382.00
GENF.L income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 382.00
GENF.L balance_sheet (annual, 2022-12-31) — Invested Capital: 2366473.00
GENF.L cash_flow (annual, 2022-12-31) — Investing Cash Flow: -2480.00
GENF.L cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 3762920.00
GENF.L cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
GENF.L cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 0.00
GENF.L cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 3762920.00
GENF.L cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: 71120.00
GENF.L income_statement (annual, 2022-12-31) — Net Income: -1335325.00
GENF.L income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -1335325.00
GENF.L income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -1335325.00
GENF.L income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -1335325.00
GENF.L income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -1335325.00
GENF.L cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -1335325.00
GENF.L income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -1335325.00
GENF.L income_statement (annual, 2022-12-31) — Net Interest Income: -382.00
GENF.L cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 0.00
GENF.L income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -382.00
GENF.L balance_sheet (annual, 2022-12-31) — Net PPE: 2351.00
GENF.L cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -2480.00
GENF.L cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 0.00
GENF.L balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 2366473.00
GENF.L income_statement (annual, 2022-12-31) — Normalized EBITDA: -1334813.00
GENF.L income_statement (annual, 2022-12-31) — Normalized Income: -1335325.00
GENF.L cash_flow (annual, 2022-12-31) — Operating Cash Flow: -1368324.00
GENF.L income_statement (annual, 2022-12-31) — Operating Income: -1334943.00
GENF.L income_statement (annual, 2022-12-31) — Operating Revenue: 0.00
GENF.L balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 292506618.00
GENF.L cash_flow (annual, 2022-12-31) — Other Cash Adjustment Outside Changein Cash: -529.00
GENF.L balance_sheet (annual, 2022-12-31) — Other Payable: 8799.00
GENF.L balance_sheet (annual, 2022-12-31) — Other Receivables: 94859.00
GENF.L income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 0.00
GENF.L balance_sheet (annual, 2022-12-31) — Payables: 92389.00
GENF.L balance_sheet (annual, 2022-12-31) — Prepaid Assets: 131414.00
GENF.L income_statement (annual, 2022-12-31) — Pretax Income: -1335325.00
GENF.L cash_flow (annual, 2022-12-31) — Purchase Of Business: 0.00
GENF.L cash_flow (annual, 2022-12-31) — Purchase Of PPE: -2480.00
GENF.L income_statement (annual, 2022-12-31) — Reconciled Depreciation: 129.00
GENF.L income_statement (annual, 2022-12-31) — Research And Development: 724465.00
GENF.L balance_sheet (annual, 2022-12-31) — Retained Earnings: -2143520.00
GENF.L cash_flow (annual, 2022-12-31) — Sale Of Business: 0.00
GENF.L income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 165889.00
GENF.L income_statement (annual, 2022-12-31) — Selling General And Administration: 665146.00
GENF.L balance_sheet (annual, 2022-12-31) — Share Issued: 292506618.00
GENF.L cash_flow (annual, 2022-12-31) — Short Term Debt Issuance: 0.00
GENF.L cash_flow (annual, 2022-12-31) — Stock Based Compensation: 72000.00
GENF.L balance_sheet (annual, 2022-12-31) — Stockholders Equity: 2366473.00
GENF.L balance_sheet (annual, 2022-12-31) — Tangible Book Value: 2366473.00
GENF.L income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
GENF.L income_statement (annual, 2022-12-31) — Tax Provision: 0.00
GENF.L income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
GENF.L balance_sheet (annual, 2022-12-31) — Taxes Receivable: 32612.00
GENF.L balance_sheet (annual, 2022-12-31) — Total Assets: 2617461.00
GENF.L balance_sheet (annual, 2022-12-31) — Total Capitalization: 2366473.00
GENF.L balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 2366473.00
GENF.L income_statement (annual, 2022-12-31) — Total Expenses: 1334943.00
GENF.L balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 250988.00
GENF.L balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 2351.00
GENF.L balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
GENF.L income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -1334943.00
GENF.L balance_sheet (annual, 2022-12-31) — Working Capital: 2364122.00
GENF.L income_statement (annual, 2023-12-31) — +Operating Expense: 1860345.00
GENF.L income_statement (annual, 2023-12-31) — +Total Revenue: 0.00
GENF.L balance_sheet (annual, 2023-12-31) — Accounts Payable: 480917.00
GENF.L balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 4190900.00
GENF.L income_statement (annual, 2023-12-31) — Basic Average Shares: 292506618.00
GENF.L income_statement (annual, 2023-12-31) — Basic EPS: -0.01
GENF.L cash_flow (annual, 2023-12-31) — Beginning Cash Position: 2356225.00
GENF.L cash_flow (annual, 2023-12-31) — Capital Expenditure: -2439.00
GENF.L balance_sheet (annual, 2023-12-31) — Capital Stock: 87752.00
GENF.L balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 683974.00
GENF.L balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 683974.00
GENF.L balance_sheet (annual, 2023-12-31) — Cash Financial: 683974.00
GENF.L cash_flow (annual, 2023-12-31) — Change In Payable: 329450.00
GENF.L cash_flow (annual, 2023-12-31) — Change In Receivables: -131014.00
GENF.L cash_flow (annual, 2023-12-31) — Change In Working Capital: 198436.00
GENF.L cash_flow (annual, 2023-12-31) — Changes In Cash: -1663314.00
GENF.L balance_sheet (annual, 2023-12-31) — Common Stock: 87752.00
GENF.L balance_sheet (annual, 2023-12-31) — Common Stock Equity: 499693.00
GENF.L cash_flow (annual, 2023-12-31) — Common Stock Issuance: 0.00
GENF.L balance_sheet (annual, 2023-12-31) — Current Assets: 1068259.00
GENF.L balance_sheet (annual, 2023-12-31) — Current Liabilities: 571960.00
GENF.L cash_flow (annual, 2023-12-31) — Depreciation: 1034.00
GENF.L cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 1034.00
GENF.L income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 1034.00
GENF.L income_statement (annual, 2023-12-31) — Depreciation Income Statement: 1034.00
GENF.L income_statement (annual, 2023-12-31) — Diluted Average Shares: 292506618.00
GENF.L income_statement (annual, 2023-12-31) — Diluted EPS: -0.01
GENF.L income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -1860345.00
GENF.L income_statement (annual, 2023-12-31) — EBIT: -1860345.00
GENF.L income_statement (annual, 2023-12-31) — EBITDA: -1859311.00
GENF.L cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -8937.00
GENF.L cash_flow (annual, 2023-12-31) — End Cash Position: 683974.00
GENF.L cash_flow (annual, 2023-12-31) — Financing Cash Flow: 0.00
GENF.L cash_flow (annual, 2023-12-31) — Free Cash Flow: -1663314.00
GENF.L income_statement (annual, 2023-12-31) — General And Administrative Expense: 352042.00
GENF.L income_statement (annual, 2023-12-31) — Interest Expense: 0.00
GENF.L income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 0.00
GENF.L balance_sheet (annual, 2023-12-31) — Invested Capital: 499693.00
GENF.L cash_flow (annual, 2023-12-31) — Investing Cash Flow: -2439.00
GENF.L cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 0.00
GENF.L cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 0.00
GENF.L cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 0.00
GENF.L cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: 0.00
GENF.L income_statement (annual, 2023-12-31) — Net Income: -1860345.00
GENF.L income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -1860345.00
GENF.L income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -1860345.00
GENF.L income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -1860345.00
GENF.L income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -1860345.00
GENF.L cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -1860345.00
GENF.L income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -1860345.00
GENF.L income_statement (annual, 2023-12-31) — Net Interest Income: 0.00
GENF.L income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 0.00
GENF.L balance_sheet (annual, 2023-12-31) — Net PPE: 3394.00
GENF.L cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -2439.00
GENF.L balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 499693.00
GENF.L income_statement (annual, 2023-12-31) — Normalized EBITDA: -1859311.00
GENF.L income_statement (annual, 2023-12-31) — Normalized Income: -1860345.00
GENF.L cash_flow (annual, 2023-12-31) — Operating Cash Flow: -1660875.00
GENF.L income_statement (annual, 2023-12-31) — Operating Income: -1860345.00
GENF.L income_statement (annual, 2023-12-31) — Operating Revenue: 0.00
GENF.L balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 292506618.00
GENF.L balance_sheet (annual, 2023-12-31) — Other Payable: 31029.00
GENF.L balance_sheet (annual, 2023-12-31) — Other Receivables: 306966.00
GENF.L income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 0.00
GENF.L balance_sheet (annual, 2023-12-31) — Payables: 511946.00
GENF.L balance_sheet (annual, 2023-12-31) — Prepaid Assets: 41041.00
GENF.L income_statement (annual, 2023-12-31) — Pretax Income: -1860345.00
GENF.L cash_flow (annual, 2023-12-31) — Purchase Of Business: 0.00
GENF.L cash_flow (annual, 2023-12-31) — Purchase Of PPE: -2439.00
GENF.L income_statement (annual, 2023-12-31) — Reconciled Depreciation: 1034.00
GENF.L income_statement (annual, 2023-12-31) — Research And Development: 1191954.00
GENF.L balance_sheet (annual, 2023-12-31) — Retained Earnings: -4003865.00
GENF.L income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 106819.00
GENF.L income_statement (annual, 2023-12-31) — Selling General And Administration: 458861.00
GENF.L balance_sheet (annual, 2023-12-31) — Share Issued: 292506618.00
GENF.L cash_flow (annual, 2023-12-31) — Stock Based Compensation: 0.00
GENF.L balance_sheet (annual, 2023-12-31) — Stockholders Equity: 499693.00
GENF.L balance_sheet (annual, 2023-12-31) — Tangible Book Value: 499693.00
GENF.L income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
GENF.L income_statement (annual, 2023-12-31) — Tax Provision: 0.00
GENF.L income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
GENF.L balance_sheet (annual, 2023-12-31) — Taxes Receivable: 36278.00
GENF.L balance_sheet (annual, 2023-12-31) — Total Assets: 1071653.00
GENF.L balance_sheet (annual, 2023-12-31) — Total Capitalization: 499693.00
GENF.L balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 499693.00
GENF.L income_statement (annual, 2023-12-31) — Total Expenses: 1860345.00
GENF.L balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 571960.00
GENF.L balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 3394.00
GENF.L balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
GENF.L income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -1860345.00
GENF.L balance_sheet (annual, 2023-12-31) — Working Capital: 496299.00
GENF.L income_statement (annual, 2024-12-31) — +Operating Expense: 1587235.00
GENF.L income_statement (annual, 2024-12-31) — +Total Revenue: 0.00
GENF.L balance_sheet (annual, 2024-12-31) — Accounts Payable: 368897.00
GENF.L balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 368897.00
GENF.L balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 4830375.00
GENF.L balance_sheet (quarterly, 2024-12-31) — Additional Paid In Capital: 4830375.00
GENF.L income_statement (annual, 2024-12-31) — Basic Average Shares: 334460024.00
GENF.L income_statement (annual, 2024-12-31) — Basic EPS: 0.00
GENF.L cash_flow (annual, 2024-12-31) — Beginning Cash Position: 683974.00
GENF.L balance_sheet (annual, 2024-12-31) — Capital Stock: 104912.00
GENF.L balance_sheet (quarterly, 2024-12-31) — Capital Stock: 104912.00
GENF.L balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 278682.00
GENF.L balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 278682.00
GENF.L balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 278682.00
GENF.L balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 278682.00
GENF.L balance_sheet (annual, 2024-12-31) — Cash Financial: 278682.00
GENF.L balance_sheet (quarterly, 2024-12-31) — Cash Financial: 278682.00
GENF.L cash_flow (annual, 2024-12-31) — Change In Payable: 239259.00
GENF.L cash_flow (annual, 2024-12-31) — Change In Receivables: 264524.00
GENF.L cash_flow (annual, 2024-12-31) — Change In Working Capital: 503783.00
GENF.L cash_flow (annual, 2024-12-31) — Changes In Cash: -425638.00
GENF.L balance_sheet (annual, 2024-12-31) — Common Stock: 104912.00
GENF.L balance_sheet (quarterly, 2024-12-31) — Common Stock: 104912.00
GENF.L balance_sheet (annual, 2024-12-31) — Common Stock Equity: -403008.00
GENF.L balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: -403008.00
GENF.L cash_flow (annual, 2024-12-31) — Common Stock Issuance: 656635.00
GENF.L balance_sheet (annual, 2024-12-31) — Current Assets: 383841.00
GENF.L balance_sheet (quarterly, 2024-12-31) — Current Assets: 383841.00
GENF.L balance_sheet (annual, 2024-12-31) — Current Liabilities: 788916.00
GENF.L balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 788916.00
GENF.L cash_flow (annual, 2024-12-31) — Depreciation: 1179.00
GENF.L cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 1179.00
GENF.L income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 1204.00
GENF.L income_statement (annual, 2024-12-31) — Depreciation Income Statement: 1204.00
GENF.L income_statement (annual, 2024-12-31) — Diluted Average Shares: 334460024.00
GENF.L income_statement (annual, 2024-12-31) — Diluted EPS: 0.00
GENF.L income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -1587235.00
GENF.L income_statement (annual, 2024-12-31) — EBIT: -1587235.00
GENF.L income_statement (annual, 2024-12-31) — EBITDA: -1586031.00
GENF.L cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 20346.00
GENF.L cash_flow (annual, 2024-12-31) — End Cash Position: 278682.00
GENF.L cash_flow (annual, 2024-12-31) — Financing Cash Flow: 656635.00
GENF.L cash_flow (annual, 2024-12-31) — Free Cash Flow: -1082273.00
GENF.L income_statement (annual, 2024-12-31) — General And Administrative Expense: 311240.00
GENF.L income_statement (annual, 2024-12-31) — Interest Expense: 0.00
GENF.L income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 0.00
GENF.L balance_sheet (annual, 2024-12-31) — Invested Capital: -403008.00
GENF.L balance_sheet (quarterly, 2024-12-31) — Invested Capital: -403008.00
GENF.L cash_flow (annual, 2024-12-31) — Investing Cash Flow: 0.00
GENF.L cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 656635.00
GENF.L cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 656635.00
GENF.L income_statement (annual, 2024-12-31) — Net Income: -1587235.00
GENF.L income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -1587235.00
GENF.L income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -1587235.00
GENF.L income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -1587235.00
GENF.L income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -1587235.00
GENF.L cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -1587235.00
GENF.L income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -1587235.00
GENF.L income_statement (annual, 2024-12-31) — Net Interest Income: 0.00
GENF.L income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 0.00
GENF.L balance_sheet (annual, 2024-12-31) — Net PPE: 2067.00
GENF.L balance_sheet (quarterly, 2024-12-31) — Net PPE: 2067.00
GENF.L cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: 0.00
GENF.L balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -403008.00
GENF.L balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: -403008.00
GENF.L income_statement (annual, 2024-12-31) — Normalized EBITDA: -1586031.00
GENF.L income_statement (annual, 2024-12-31) — Normalized Income: -1587235.00
GENF.L cash_flow (annual, 2024-12-31) — Operating Cash Flow: -1082273.00
GENF.L income_statement (annual, 2024-12-31) — Operating Income: -1587235.00
GENF.L income_statement (annual, 2024-12-31) — Operating Revenue: 0.00
GENF.L balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 349706618.00
GENF.L balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 349706618.00
GENF.L balance_sheet (annual, 2024-12-31) — Other Payable: 17243.00
GENF.L balance_sheet (quarterly, 2024-12-31) — Other Payable: 17243.00
GENF.L balance_sheet (annual, 2024-12-31) — Other Receivables: 4749.00
GENF.L balance_sheet (quarterly, 2024-12-31) — Other Receivables: 4749.00
GENF.L income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
GENF.L balance_sheet (annual, 2024-12-31) — Payables: 386140.00
GENF.L balance_sheet (quarterly, 2024-12-31) — Payables: 386140.00
GENF.L balance_sheet (annual, 2024-12-31) — Prepaid Assets: 68653.00
GENF.L balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 68653.00
GENF.L income_statement (annual, 2024-12-31) — Pretax Income: -1587235.00
GENF.L cash_flow (annual, 2024-12-31) — Purchase Of PPE: 0.00
GENF.L income_statement (annual, 2024-12-31) — Reconciled Depreciation: 1179.00
GENF.L income_statement (annual, 2024-12-31) — Research And Development: 1151461.00
GENF.L balance_sheet (annual, 2024-12-31) — Retained Earnings: -5591100.00
GENF.L balance_sheet (quarterly, 2024-12-31) — Retained Earnings: -5591100.00
GENF.L income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 97049.00
GENF.L income_statement (annual, 2024-12-31) — Selling General And Administration: 408289.00
GENF.L balance_sheet (annual, 2024-12-31) — Share Issued: 349706618.00
GENF.L balance_sheet (quarterly, 2024-12-31) — Share Issued: 349706618.00
GENF.L cash_flow (annual, 2024-12-31) — Stock Based Compensation: 0.00
GENF.L balance_sheet (annual, 2024-12-31) — Stockholders Equity: -403008.00
GENF.L balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: -403008.00
GENF.L balance_sheet (annual, 2024-12-31) — Tangible Book Value: -403008.00
GENF.L balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: -403008.00
GENF.L income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
GENF.L income_statement (annual, 2024-12-31) — Tax Provision: 0.00
GENF.L income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00